Request Deal Involvement
Viatris completed the acquisition of a 5.1% stake in Syngene from Biocon for $153m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Avendus
or
Principals
target
SYNGENE
vendor
BIOCON BIOLOGICS LTD
bidder
VIATRIS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite